SEAMAN FURNITURE CO INC
SC 13D/A, 1997-08-14
FURNITURE STORES
Previous: PEOPLES FINANCIAL CORP, 10-Q, 1997-08-14
Next: SEAMAN FURNITURE CO INC, SC 13D/A, 1997-08-14



                                  UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                             Washington, D.C. 20549

                                  SCHEDULE 13D

                    Under the Securities Exchange Act of 1934

                               (Amendment No. 6)*


                         Seaman Furniture Company, Inc.
                     ---------------------------------------
                                (Name of Issuer)


                          Common Stock, $.01 par value
                     ---------------------------------------
                         (Title of Class of Securities)


                                        812163103
                     ---------------------------------------
                                  (CUSIP Number)


                 Fred M. Stone, Esq., M.D. Sass Associates, Inc.
                 1185 Avenue of the Americas, New York, NY 10036
                     ---------------------------------------
            (Name, Address and Telephone Number of Person Authorized
                     to Receive Notices and Communications)


                               August 13, 1997
                     ---------------------------------------
             (Date of Event which Requires Filing of this Statement)


If the filing person has previously filed a statement on Schedule 13G to report
the acquisition which is the subject of this Schedule 13D, and is filing this
schedule because of Rule 13d-1(b)(3) or (4), check the following box.

Check the following box if a fee is being paid with the statement.  (A fee is
not required only if the reporting person:  (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)

Note:  Six copies of this statement, including all exhibits, should be filed
with the Commission.  See Rule 13d-1(a) for other parties to whom copies are to
be sent.

*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103                                         Page 2 of 19 Pages

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass Re/Enterprise Partners, L.P.
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY


4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware

NUMBER OF 7    SOLE VOTING POWER
               1,360,865 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               1,360,865 (1)

WITH 10   SHARED DISPOSITIVE POWER
          - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     1,360,865 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     29.99%

14   TYPE OF REPORTING PERSON *
     PN

(1) Voting and dispositive power is exercised through its managing general
partner, M.D. Sass Associates, Inc.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass Associates, Inc.
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware

NUMBER OF 7    SOLE VOTING POWER
               1,360,865 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               1,360,865 (1)

WITH 10   SHARED DISPOSITIVE POWER
          - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     1,360,865 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     29.99%

14   TYPE OF REPORTING PERSON *
     CO

(1) Voting and dispositive power is exercised solely in its capacity as managing
general partner of M.D. Sass Re/Enterprise Partners, L.P.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass Parallax Partners, L.P.
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware

NUMBER OF 7    SOLE VOTING POWER
               34,916 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               34,916 (1)

WITH      10   SHARED DISPOSITIVE POWER
               -0-

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     34,916 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     0.77%

14   TYPE OF REPORTING PERSON *
     PN

 (1) Voting and dispositive power is exercised through its sole general partner,
M.D. Sass GPU Inc.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass GPU Inc.
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware

NUMBER OF 7    SOLE VOTING POWER
               34,916 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               34,916 (1)
WITH 10   SHARED DISPOSITIVE POWER
          - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     34,916 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     0.77%
14   TYPE OF REPORTING PERSON *
     CO

 (1) Voting and dispositive power is exercised solely in its capacity as sole
general partner of M.D. Sass Parallax Partners, L.P.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass Associates, Inc. Employees Profit Sharing Plan
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     New York

NUMBER OF 7    SOLE VOTING POWER
               23,075
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               23,075

WITH      10   SHARED DISPOSITIVE POWER
               - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     23,075

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     0.51%

14   TYPE OF REPORTING PERSON *
     EP


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass Re/Enterprise International, Ltd.
Citco Building, Wickhams Cay, P.O. Box 662, Road Town, Tortola,
British Virgin Islands

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     British Virgin Islands

NUMBER OF 7    SOLE VOTING POWER
               157,231 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               157,231 (1)

WITH      10   SHARED DISPOSITIVE POWER
               - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     157,231 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     3.47%
14   TYPE OF REPORTING PERSON *
     CO

(1) Voting and dispositive power is exercised through its investment advisor,
M.D. Sass Management, Inc.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass Management, Inc.
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware

NUMBER OF 7    SOLE VOTING POWER
               157,231 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               157,231 (1)

WITH      10   SHARED DISPOSITIVE POWER
               - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     157,231 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     3.47%

14   TYPE OF REPORTING PERSON *
     CO

(1) Voting and dispositive power is exercised solely in its capacity as
investment manager of M.D. Sass Re/Enterprise International, Inc.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
J.B. Rubin & Co. Defined Contribution Plan
M.D. Sass Associates, Inc., 1185 Avenue of the Americas, New York, New York
10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     New York

NUMBER OF 7    SOLE VOTING POWER
               1,450 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               1,450 (1)

WITH      10   SHARED DISPOSITIVE POWER
               - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     1,450 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     0.03%

14   TYPE OF REPORTING PERSON *
     00

 (1) Voting and dispositive power is exercised through its trustee, James B.
Rubin.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
Corporate Renaissance Group, Inc.
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware

NUMBER OF 7    SOLE VOTING POWER
               148,824 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               148,824 (1)

WITH      10   SHARED DISPOSITIVE POWER
               - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     148,824 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     3.28%

14   TYPE OF REPORTING PERSON *
     CO

(1) Voting and dispositive power is exercised through its investment manager,
M.D. Sass Investors Services, Inc.


<PAGE>


                                  SCHEDULE 13D

CUSIP NO.  812163103

1    NAME OF REPORTING PERSON
S.S. OR I.R.S. IDENTIFICATION NO. OF ABOVE PERSON
M.D. Sass Investors Services, Inc.
1185 Avenue of the Americas, New York, New York  10036

2    CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP* (a)       (b)

3    SEC USE ONLY

4    SOURCE OF FUNDS*
     00

5    CHECK BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS
2(d) or 2(e)

6    CITIZENSHIP OR PLACE OF ORGANIZATION
     Delaware

NUMBER OF 7    SOLE VOTING POWER
               148,824 (1)
SHARES
BENEFICIALLY
OWNED BY  8    SHARED VOTING POWER
               - 0 -
EACH
REPORTING
PERSON    9    SOLE DISPOSITIVE POWER
               148,824 (1)

WITH      10   SHARED DISPOSITIVE POWER
               - 0 -

11   AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
     148,824 (1)

12   CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES*

13   PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
     3.28%

14   TYPE OF REPORTING PERSON *
     CO

(1) Voting and dispositive power is exercised solely in its capacity as
investment adviser to Corporate Renaissance Group, Inc.


<PAGE>


                                  SCHEDULE 13D
                    Under the Securities Exchange Act of 1934

                                (Amendment No. 4)


Item 1.   Security and Issuer.

      This  Amendment No. 6 amends and supplements the Schedule 13D filed on  13
April  1993 (the "Schedule 13D Report") by T. Rowe Price Recovery Fund, L.P.,  a
Delaware  limited  partnership ("Recovery Fund"), T. Rowe  Price  Recovery  Fund
Associates,  Inc.,  a  Maryland corporation ("Recovery Associates"),  M.D.  Sass
Re/Enterprise  Partners, L.P., a Delaware limited partnership ("Re/Enterprise"),
M.D.  Sass  Associates, Inc., a Delaware corporation ("Associates"),  M.D.  Sass
Parallax Partners, L.P., a Delaware limited partnership ("Parallax"), M.D.  Sass
GPU  Inc.,  a  Delaware  corporation ("GPU"), and  M.D.  Sass  Associates,  Inc.
Employees Profit Sharing Plan, a trust ("SAEPS") as the Reporting Persons  named
therein  relating to the Common Stock, par value $.01 per share ("Common Stock")
of  Seaman  Furniture  Company, Inc. (the "Issuer"),  and  Amendment  No.  1  to
Schedule  13D  filed  on March 14, 1994 by Re/Enterprise, Associates,  Parallax,
GPU,  SAEPS,  M.D.  Sass  Re/Enterprise International, Ltd.,  a  British  Virgin
Islands  Corporation ("International"), M.D. Sass Management, Inc.,  a  Delaware
corporation ("Management"), and the J.B. Rubin & Co. Defined Contribution  Plan,
a trust (the "Rubin Plan"), Amendment No. 2 to Schedule 13D filed on January 12,
1996   by   Re/Enterprise,  Associates,  Parallax,  GPU,  SAEPS,  International,
Management,   M.D.  Sass  Investors  Services,  Inc.,  a  Delaware   corporation
("Investors"),  Corporate Renaissance Group, Inc. ("CREN") and the  Rubin  Plan,
Amendment  No.  3  to  Schedule 13D filed on April 17,  1996  by  Re/Enterprise,
Associates, Parallax, GPU, SAEPS, International, Management, Investors, CREN and
the Rubin Plan, and Amendment No. 4 to Schedule 13D filed on October 3, 1996, by
Re/Enterprise,  Associates,  Parallax, GPU,  SAEPS,  International,  Management,
Investors, CREN and the Rubin Plan, and Amendment No. 5 to Schedule 13D filed on
July   15,   1997,   by   Re/Enterprise,  Associates,  Parallax,   GPU,   SAEPS,
International,  Management,  Investors, CREN and the  Rubin  Plan.   Capitalized
terms used herein without specific definition have the respective meanings given
them in the Schedule 13D Report.

Item 4.   Purpose of Transaction.

      Item  4 of the Schedule 13D Report and Amendment No. 1, Amendment  No.  2,
Amendment No. 3, Amendment No. 4, and Amendment No. 5 is hereby restated in  its
entirety to read as follows:

      The  Reporting  Persons, together with T. Rowe Price Associates  Inc.  and
affiliated entities, Carl Marks Management Company, L.P. and affiliated entities
(collectively, the "Participating Funds"), and members of senior  management  of
the  Company  including Alan Rosenberg, Steven Halper and  Peter  McGeough  (the
"Participating  Executives"), presented a proposal to  the  Company's  Board  of
Directors  on  July  8,  1997  to acquire, through  a  merger  transaction,  the
approximately 20% of the Company's outstanding Common Stock not already owned by
the foregoing persons for $24.00 per share.  The proposal was subject to certain
conditions,  including, among other things, approval by a special  committee  of
the  Company's  board  of  directors, obtaining  acceptable  financing  and  the
negotiation of a mutually acceptable merger agreement.

     The Reporting Persons together with the Participating Funds have formed SFC
Merger  Company,  a Delaware corporation ("Newco"), solely for  the  purpose  of
acquiring  approximately  20%  of the Company's  outstanding  Common  Stock  not
already  owned  by the foregoing persons (the "Public Stock"), and  have  caused
Newco, as its sole stockholders, to enter into a definitive merger agreement  on
August  13, 1997, to purchase, through a one-step merger transaction, the Public
Stock  for  $25.05  per share.  Consummation of the transaction  is  subject  to
certain   conditions,   including  among  other  things,  obtaining   acceptable
financing.

Item 5.   Interest in Securities of the Issuer

      Item  5  of  the  Schedule 13D Report, Amendment No. 1, Amendment  No.  2,
Amendment  No. 3, Amendment No. 4, and Amendment No. 5 has not been amended  and
is hereby restated to read in its entirety as follows:

     (a)  Re/Enterprise, Parallax, SAEPS, International, the Rubin Plan and CREN
held  directly  and  of record 1,360,865 shares, 34,916 shares,  23,075  shares,
157,231 shares, 1,450 shares and 148,824 shares, respectively, of Common  Stock,
representing  approximately  29.99%,  0.77%,  0.51%,  3.47%,  0.03%  and  3.28%,
respectively, of the Issuer's outstanding Common Stock as of July 8, 1997.

      Such  determinations  are  based on representations  of  the  Issuer  that
4,537,041 shares of Common Stock were issued and outstanding as of September  9,
1996.

      Of  the aggregate amount held by Re/Enterprise, Associates, as the general
partner of Re/Enterprise, may be deemed to own beneficially the 1,360,865 shares
of Common Stock held by Re/Enterprise.

     Of the aggregate amount held by Parallax, GPU., as the sole general partner
of Parallax, may be deemed to own beneficially the 34,916 shares of Common Stock
held by Parallax.

      Of  the  aggregate  amount  held  by  International,  Management,  as  the
investment  manager  of  International, may be deemed to  own  beneficially  the
157,231 shares of Common Stock held by International.

      Of  the  aggregate amount held by the Rubin Plan, James B. Rubin,  as  the
trustee of the Rubin Plan, may be deemed to own beneficially the 1,450 shares of
Common Stock held by the Rubin Plan.

      Of the aggregate amount held by CREN, Investors, as the investment manager
of  CREN,  may be deemed to own beneficially the 148,824 shares of Common  Stock
held by CREN.

      The  Reporting Persons do not beneficially own any other shares of  Common
Stock.

      By reason of the Merger Agreement, the Reporting Persons may be deemed  to
be  a "group", within the meaning of Rule 13d-5 under the Exchange Act, with the
Participating  Funds  and the Participating Executives and  therefore  to  share
beneficial  ownership, within the meaning of Rule 13d-1 under the Exchange  Act,
of  the  shares  of  Common Stock beneficially owned by such  persons.   To  the
knowledge of the Reporting Persons, based upon Schedule 13D or 13G filings (with
respect  to  the Participating Funds) and information furnished by  the  Company
(with  respect to the Participating Executives), on the date hereof such persons
beneficially owned the amounts of common stock respectively indicated below:

     Party (ies)                                  No. of Shares
T. Rowe Price Associates, Inc.
    And Affiliates                                967,900 Shares

Carl Marks Management Company, L.P.
   And Affiliates                                      938,050 Shares

Participating Executives
(including shares subject to stock options)            705,752 Shares

      (b)  (i)  Re/Enterprise has the sole power to vote or direct the vote  and
sole power to dispose or to direct the disposition of the securities of which it
is  beneficial  owner.   Such power is exercised through  its  general  partner,
Associates.  Accordingly, Associates may be deemed to share in the power to vote
or  direct the vote and power to dispose or to direct the disposition of all  of
the shares of Common Stock held Re/Enterprise.

           (ii) Parallax has the sole power to vote or direct the vote and  sole
power  to dispose or to direct the disposition of the securities of which it  is
beneficial  owner.   Such power is exercised through its general  partner,  GPU.
Accordingly, GPU may be deemed to share in the power to vote or direct the  vote
and power to dispose or to direct the disposition of all of the shares of Common
Stock held Parallax.

          (iii)     SAEPS has the sole power to vote or direct the vote and sole
power  to dispose or to direct the disposition of the securities of which it  is
beneficial owner.  Such power is exercised through its Board of Trustees.

           (iv) International has the sole power to vote or direct the vote  and
sole power to dispose or to direct the disposition of the securities of which it
is  beneficial  owner.  Such power is exercised through its investment  manager,
Management.  Accordingly, Management may be deemed to share in the power to vote
or  direct the vote and power to dispose or to direct the disposition of all  of
the shares of Common Stock held by International.

           (v)  The Rubin Plan has the sole power to vote or direct the vote and
sole power to dispose or to direct the disposition of the securities of which it
is  beneficial  owner.  Such power is exercised through its  trustee,  James  B.
Rubin.  Accordingly, James B. Rubin may be deemed to share in the power to  vote
or  direct the vote and power to dispose or direct the disposition of all of the
shares of Common Stock held by the Rubin Plan.

          (vi) CREN has the sole power to vote or direct the vote and sole power
to dispose or direct the disposition of the securities of which it is beneficial
owner.   Such  power  is  exercised through its investment  manager,  Investors.
Accordingly, Investors may be deemed to share in the power to vote and power  to
dispose  or direct the disposition of all of the shares of Common Stock held  by
CREN.

           (vii)     Pursuant to Section 240.13d-4, Mr. Rubin, Associates,  GPU,
Management and Investors, on behalf of themselves and their affiliates, disclaim
beneficial  ownership of the Common Stock held or managed for  the  accounts  of
others,  and the filing of this Schedule 13D by, or the naming of such  persons,
shall  not be construed as an admission that any such person or entity  is,  for
the  purposes of Sections 13 or 16 of the Securities Exchange Act of  1934,  the
beneficial owner of any such securities of the Issuer.

     (c)  By reason of the Merger Agreement, the Reporting Persons may be deemed
to have acquired shared beneficial ownership of the shares of Common Stock owned
by  the Participating Funds and the Participating Executives on or about July 8,
1997.   Except as aforesaid, there were no transactions in the Common  Stock  by
any of the reporting persons during the past sixty (60) days.

Item 6.   Contracts, Arrangements, Understandings or
     Relationships with Respect to Securities of the Issuer

      Item  6 of the Schedule 13D Report and Amendment No. 1, Amendment  No.  2,
Amendment No. 3, Amendment No. 4 and Amendment No. 5 is hereby amended  to  read
as follows:

      Pursuant to a letter agreement, certain of the Reporting Persons, together
with  the  Participating Funds and the Participating Executives,  have  retained
Wheat  First Securities, Inc. as financial advisor in connection with the merger
transaction described in Item 4.

     The response to Item 4 is incorporated herein by this reference.

      The  Reporting Persons together with the Participating Funds, as the  sole
stockholders  of  Newco,  have caused Newco to enter into  a  definitive  merger
agreement with the Company in connection with the transaction described in  Item
4.

     The merger contained in Item 4 is qualified in its entirety by reference to
the  Agreement  and  Plan of Merger by and between the Company  and  SFC  Merger
Company, dated August 13, 1997, a copy of which is filed as Exhibit 2.1  to  the
Form  8-K  filed by the Company on August 14, 1997, and incorporated  herein  by
reference.

Item 7.   Materials to be Filed as Exhibits

     Exhibit A -    Joint Filing Agreement pursuant to Rule 13d-1(f)(1)(iii)



<PAGE>


     After reasonable inquiry and to the best of my knowledge and belief, the
undersigned certify that the information set forth in this statement is true,
complete and correct.  Dated August 14, 1997.

M.D. SASS RE/ENTERPRISE INTERNATIONAL, LTD.
By:  M.D. Sass Management, Inc.

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter
     Senior Vice President


M.D. SASS RE/ENTERPRISE PARTNERS, L.P.
By:  M.D. Sass Associates, Inc.,
   its General Partner

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter
     Senior Vice President


M.D. SASS PARALLAX PARTNERS, L.P.
By:  M.D. Sass GPU Inc., its General Partner

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter, Treasurer


M.D. SASS ASSOCIATES, INC.
EMPLOYEES PROFIT SHARING PLAN

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter
     Trustee


M.D. SASS MANAGEMENT, INC.

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter
     Senior Vice President


M.D. SASS ASSOCIATES, INC.

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter
     Senior Vice President


M.D. SASS GPU INC.

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter, Treasurer


M.D. SASS INVESTORS SERVICES, INC.

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter
     Senior Vice President


CORPORATE RENAISSANCE GROUP INC.

By:    /s/ Martin E. Winter
     ---------------------------------------
     Martin E. Winter
     Treasurer


J. B. RUBIN & CO. DEFINED CONTRIBUTION PLAN

By:    /s/ James B. Rubin
     ---------------------------------------
     James B. Rubin
     Trustee


   EXHIBIT A Joint Filing Agreement
  In accordance with Rule 13d-1(f)(1) of Regulation 13D-G of the General Rules
and Regulations of the Securities and Exchange Commission under the Securities
Exchange Act of 1934, as amended, the undersigned agree to the joint filing on
behalf of each of them to this statement and any subsequent amendments hereto.
Dated October 3, 1996.

M.D. SASS RE/ENTERPRISE INTERNATIONAL, LTD.
By:  M.D. Sass Management, Inc.

By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter
Senior Vice President

M.D. SASS RE/ENTERPRISE PARTNERS, L.P.
By:  M.D. Sass Associates, Inc.,
   its General Partner

By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter
Senior Vice President

M.D. SASS PARALLAX PARTNERS, L.P.
By:  M.D. Sass GPU Inc., its General Partner

By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter, Treasurer

M.D. SASS ASSOCIATES, INC.
EMPLOYEES PROFIT SHARING PLAN

By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter
Trustee

M.D. SASS MANAGEMENT, INC.

By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter
Senior Vice President

M.D. SASS ASSOCIATES, INC.

By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter
Senior Vice President

M.D. SASS GPU INC.

By:    /s/ Martin E. Winter
- ---------------------------------------
Martin E. Winter, Treasurer

M.D. SASS INVESTORS SERVICES, INC.
By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter
Senior Vice President

CORPORATE RENAISSANCE GROUP INC.

By:    /s/ Martin E. Winter
- --------------------------------------
Martin E. Winter
Treasurer

J. B. RUBIN & CO. DEFINED CONTRIBUTION PLAN

By:    /s/ James B. Rubin
- --------------------------------------
James B. Rubin
Trustee



© 2022 IncJournal is not affiliated with or endorsed by the U.S. Securities and Exchange Commission